Is Ketamine an Opioid?

No, ketamine is not an opioid. This common misconception causes confusion for families researching substance use and treatment options. Ketamine belongs to a drug class called dissociative anesthetics. These work through a distinct brain mechanism compared to opioids like morphine or heroin.

At Liberty Wellness, we recognize that accurate information forms the foundation of effective treatment. Whether you’re concerned about ketamine use, opioid addiction, or other substance-related issues, our team provides comprehensive assessments and personalized care. Understanding what ketamine is and how it differs from opioids represents the first step toward making informed decisions about medical addiction treatment and recovery support.

What is Ketamine?

Surgeons have relied on ketamine as an anesthetic since the 1960s, when researchers first developed it for medical procedures. Doctors continue to use it in medical settings for anesthesia and pain management because it works quickly and maintains breathing function better than many alternatives. The U.S. Food and Drug Administration classifies ketamine as a Schedule III controlled substance, recognizing both its legitimate medical uses and its potential for misuse.

The drug appears in several forms depending on its intended use:

• Medical applications: Injectable liquid administered during surgery, FDA-approved nasal spray (Spravato) for treatment-resistant depression
• Illicit versions: White powder, tablets, or liquid diverted from medical supplies
• Street names: Special K, K, Cat Valium, Vitamin K

Ketamine’s chemical structure places it in a unique class of drugs, distinct from opioids, stimulants, and benzodiazepines. This chemical classification reflects its unique structure and mechanism of action in the brain.

Knowing exactly what substance someone has taken can be life-saving. Doctors treat ketamine overdoses completely differently than opioid emergencies, and recovery approaches vary just as dramatically.

How Does Ketamine Work in the Brain?

Ketamine works by blocking N-methyl-D-aspartate (NMDA) receptors in the brain. These receptors normally respond to glutamate, a neurotransmitter that sends excitatory signals throughout the nervous system. When ketamine blocks these receptors, it disrupts normal brain communication. This creates what researchers call dissociative anesthesia. It is a trance-like state where people feel detached from their surroundings.

This mechanism is completely different from how opioids work. According to the National Institute on Drug Abuse, opioids bind to mu-opioid receptors. These receptors are found throughout the brain and body, mimicking natural pain-relieving chemicals. This binding produces pain relief, euphoria, and potentially dangerous respiratory depression. Ketamine’s NMDA antagonism creates pain relief through an entirely different pathway that doesn’t typically cause the same breathing problems.

The drug’s effects on multiple neurotransmitter systems include:

• Glutamate disruption: Blocks excitatory signals that transmit pain and other sensations
• Dopamine influence: Affects reward pathways in ways distinct from opioid-induced dopamine release
• Dissociative states: Creates feelings of detachment not seen with opioid medications

These different brain mechanisms explain why ketamine isn’t an opiate, even though both substances affect pain and mood.

What are the Similarities and Differences Between Ketamine and Opioids?

Ketamine and opioids do share some similarities. They both change brain chemistry and can create dependence over time. They affect neurotransmitters, carry misuse risks, and require professional oversight during treatment.

But that’s where the common ground stops. Ketamine blocks NMDA receptors, disrupting glutamate transmission to create dissociative effects. Opioids activate mu-, delta-, and kappa-opioid receptors, mimicking natural endorphins to produce pain relief and euphoria. Research shows ketamine’s S-isomer can bind to opioid receptors at higher doses. This creates some overlap in effects but does not make ketamine an opioid.

Pain management applications:

• Ketamine approach: Works through NMDA antagonism, providing pain relief without respiratory depression
• Opioid approach: Binds to opioid receptors, offering pain relief but carrying high overdose risk
• Clinical advantage: Meta-analyses confirm ketamine reduces acute pain as effectively as morphine with less nausea

The legal system classifies these drugs differently based on their medical value and abuse potential. The Drug Enforcement Administration places ketamine in Schedule III, recognizing moderate abuse potential. Most prescription opioids sit in Schedule II, indicating higher abuse potential with severe dependence risk.

Preliminary research suggests ketamine may help treat opioid use disorder through its NMDA antagonism. Eight human trials through 2024 examined whether intravenous, sublingual, or oral ketamine could reduce opioid withdrawal symptoms. Results showed promise, though evidence remains limited and requires further study.

Can You Get Addicted to Ketamine?

Ketamine is addictive, though its potential for dependence differs from that of opioids. The National Institute on Drug Abuse has found that ketamine creates primarily psychological addiction, unlike opioids which cause intense physical dependence. The drug’s dissociative effects can lead people to use it repeatedly to escape reality or manage emotional distress.

While ketamine doesn’t typically cause the severe physical withdrawal symptoms associated with opioids, regular users can develop tolerance and cravings. Research from 2023 indicates approximately 1.3% of people aged 12 and older reported ketamine use in the past year, with addiction rates varying based on frequency and context of use.

Ketamine dependence is primarily psychological, while opioids cause both physical and psychological dependence. Physical dependence occurs when the body adapts to a substance and requires it to function normally. Psychological dependence involves emotional and mental reliance on a substance to cope with daily life.

Risk factors for ketamine addiction:

• Mental health conditions: Depression, anxiety, PTSD, or other psychiatric disorders increase vulnerability
• Frequency of use: Regular use, especially more than once weekly, accelerates tolerance and dependence
• Co-occurring substance use: Using multiple substances compounds effects on brain chemistry
• Environmental factors: Peer influence, trauma history, and lack of social support contribute to risk

Research from 2023 shows ketamine’s psychological addiction often develops in people using it to self-medicate depression or anxiety. The drug’s rapid effects can create a cycle where users repeatedly seek relief through ketamine rather than addressing underlying conditions through comprehensive treatment.

What Are the Short-Term and Long-Term Effects of Ketamine?

Ketamine affects people differently depending on how long they’ve been using it. Short-term effects appear within minutes and typically last one to two hours. Long-term use can lead to serious health problems that may persist even after stopping the drug.

Immediate effects include:

• Dissociation: Sense of floating or watching oneself from outside the body
• Pain relief: Reduced awareness of physical discomfort lasting 30 to 60 minutes
• Mood changes: Feelings ranging from euphoria to confusion, anxiety, or panic
• Physical symptoms: Nausea, blurred vision, coordination difficulties, changes in blood pressure

The intensity depends on dose, method of use, and individual brain chemistry. Higher doses increase the risk of a “K-hole.” This is a state of near-complete dissociation that can be frightening.

Repeated ketamine use damages multiple body systems over time. Research from 2022 through 2024 shows chronic users face significant health risks. The bladder experiences severe damage, developing ketamine-induced cystitis. Symptoms include painful urination, blood in urine, and frequent bathroom trips. Up to 90% of regular ketamine users develop bladder problems, with some requiring surgical intervention.

Cognitive function declines with regular use. Studies from 2023 found people who use ketamine multiple times per week show measurable problems with memory formation, attention span, and decision-making. MRI studies from 2024 show reduced gray matter volume in brain areas responsible for memory and learning. These changes can persist for months or years after stopping use.

What Are the Risks of Mixing Ketamine with Other Substances?

Mixing ketamine with other drugs that slow down the brain (like opioids, alcohol, or benzodiazepines) can be deadly. When ketamine interacts with opioids, alcohol, or benzodiazepines, the effects of both substances intensify, potentially leading to respiratory failure, loss of consciousness, and overdose.

According to the Substance Abuse and Mental Health Services Administration, emergency department visits involving ketamine combined with opioids increased by 34% between 2022 and 2024. The Drug Abuse Warning Network reported that polysubstance cases involving ketamine accounted for approximately 68% of ketamine-related emergency visits in 2023.